Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Partha Manas Das"'
Publikováno v:
Journal of Clinical Oncology. 39:e13507-e13507
e13507 Background: Dozens of genetic aberrations have become druggable targets or act as biomarkers of diseases for which pts may qualify for precision medicine treatment options. Biomarker informed treatments can lead to vast improvements in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62bd1520ddbd555c909a2f09733f1853
https://doi.org/10.1200/jco.2021.39.15_suppl.e13507
https://doi.org/10.1200/jco.2021.39.15_suppl.e13507
Autor:
Aurelien Jamotte, Ann Xi, Partha Manas Das, Allison Petrilla, Nathan Markward, Kendall Lee Stevinson, Ehab Elkhouly, Barton Jones, Anne Murunga, Tara Matsuda, Anik R Patel
Publikováno v:
Journal of Clinical Oncology. 38:278-278
278 Background: The number of targeted therapies approved for treatment of mNSCLC has increased over the past 5 years. Strategies to identify eligible patients with actionable mutations for targeted therapy include simultaneous testing of ≥ 2 genes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87e7d2f229284b3dbab0fa0cac8f84ec
https://doi.org/10.1200/jco.2020.38.29_suppl.278
https://doi.org/10.1200/jco.2020.38.29_suppl.278
Publikováno v:
Anticancer research. 27(2)
The role of selenium in reducing the risk of multiple cancers has been described in the literature. Although reports have described the antiproliferative and pro-apoptotic function of selenium by up-regulation of genes in these pathways, information
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4531d0429ec1177d595968307d44e4d4
https://pubmed.ncbi.nlm.nih.gov/17465221
https://pubmed.ncbi.nlm.nih.gov/17465221